Goldline Pharmaceutical IPO

Listed SME IPO SME Platform

Listed 19 May 2026 · updated 4 months ago

Price band

₹43

GMP

+₹15

Est. listing price₹58

Est. listing gain34.88%

Issue size₹11.61 Cr

GMP Calculator Compare

Goldline Pharmaceutical IPO Details

Open DateTue, 12 May 2026

Close DateThu, 14 May 2026

Listing DateTue, 19 May 2026

Listing AtSME Platform

Price Band₹43 per share

Lot SizeAwaited

Min. InvestmentAwaited

Issue Size₹11.61 Cr

Goldline Pharmaceutical IPO Dates & Timeline

Tentative dates follow SEBI's T+3 listing timeline

IPO Opens

Tue, 12 May

IPO Closes

Thu, 14 May

Basis of Allotment

Fri, 15 May

Tentative

Refunds Initiated

Mon, 18 May

Tentative

Shares Credited to Demat

Mon, 18 May

Tentative

Listing Date

Tue, 19 May

Goldline Pharmaceutical IPO GMP Today

All IPO GMP

GMP today +₹15

Est. listing price ₹58

Est. gain % 34.88%

Est. profit / lot —

GMP is an unofficial grey-market indicator and can change quickly. It does not guarantee listing gains. Try the GMP calculator · What is GMP? · GMP of all IPOs

Final visitor sentiment

Visitor opinion poll, not investment advice.

0 votes

Will apply 0%

Will skip 0%

Not sure 0%

Goldline Pharmaceutical IPO Allotment Status

Check allotment on the registrar’s website or the exchange websites using your PAN or application number.

BSE NSE

New to this? Read how to check IPO allotment status or see all IPOs awaiting allotment.

About Goldline Pharmaceutical IPO

Goldline Pharmaceutical is an SME IPO worth ₹11.61 crore with a price band of ₹43 per share. The issue opens on 12 May 2026 and closes on 14 May 2026. Shares are expected to list on 19 May 2026 on SME Platform.

Goldline Pharmaceutical IPO: FAQs

What is the price band of Goldline Pharmaceutical IPO?

The Goldline Pharmaceutical IPO price band is ₹43 per share and the issue size is ₹11.61 crore.

When does Goldline Pharmaceutical IPO open and close?

Goldline Pharmaceutical IPO opens for subscription on Tuesday, 12 May 2026 and closes on Thursday, 14 May 2026. Bids are accepted until 5 PM on the closing day.

What is the Goldline Pharmaceutical IPO allotment date?

The basis of allotment for Goldline Pharmaceutical IPO is expected to have been finalised on Friday, 15 May 2026, one working day after the issue closes (SEBI T+3 timeline).

How to check Goldline Pharmaceutical IPO allotment status?

Visit the registrar's allotment page, select Goldline Pharmaceutical IPO and search by PAN or application number. You can also check on the IPO allotment status page or on the BSE and NSE websites.

When is Goldline Pharmaceutical IPO listing date?

Goldline Pharmaceutical shares listed on SME Platform on Tuesday, 19 May 2026.

Is Goldline Pharmaceutical a mainboard or SME IPO?

Goldline Pharmaceutical is an SME IPO, listing on the SME Platform platform. Individual investors must apply for at least two lots in SME IPOs.

Last updated 11 May 2026, 11:44 AM IST. GMP is unofficial and indicative; dates after the issue closes are tentative. Not investment advice.